Furthermore, we analyze recent breakthroughs in smart delivery systems that enable sequential release of multiple bioactive agents (e.g., nanoceria and erythropoietin, aspirin and erythropoietin), and discuss emerging innovations in stimuli-responsive injectable hydrogels that can respond to the local microenvironment of periodontitis, providing temporally controlled therapeutic effects at the disease site. Here, EPO is linked to periodontitis.